Dr Tan Chee Seng

Dr Tan Chee Seng is a Senior Medical Oncologist at OncoCare Cancer Centre. His subspecialty interests are in thoracic/lung (small cell and non-small cell lung cancers, mesothelioma) and head/neck cancers (including nasopharyngeal carcinoma, NPC). He has more than 20 years of clinical practice.

He obtained his undergraduate medical degree from the School of Medicine, National University of Singapore, and his post-graduate qualification from the Royal College of Physicians, United Kingdom. He completed his advanced specialist training in Medical Oncology from National University Hospital. He was later awarded the prestigious Academic Medicine Development Award (AMDA) fellowship to subspecialize in the personalization of lung cancer therapies at Addenbrooke’s Hospital, Cambridge University, United Kingdom.

Before entering private practice, Dr Tan Chee Seng was a Consultant with the Haematology-Oncology Department of the National University Cancer Institute of Singapore (NCIS), National University Hospital (NUH), and a Visiting Consultant at Ng Teng Fong General Hospital (NTFGH).

Dr Tan Chee Seng had been invited to speak or to chair local and regional oncology meetings. He also routinely held public talks with local GPs to inform them of the latest innovative treatments for cancers. Dr Tan was also the recipient of several grants including the National Medical Research Council (NMRC) Clinician Investigator Salary Support Programme and Investigational Medicine Unit (IMU) Bridging Funds.

He is a member of several professional bodies including the American Society of Clinical Oncology (ASCO), the European Society of Medical Oncology (ESMO), the International Association for the Study of Lung Cancer (IASLC), and was an executive committee member of the Singapore Society of Oncology.

He was actively involved in both undergraduate and postgraduate teachings at the Yong Loo Lin School of Medicine (YLLSOM) and the National University Hospital (NUH) respectively. He was previously appointed as the Assistant Professor for the Faculty of Medicine, YLLSOM, and Undergraduate Education Director (Medical Oncology). He was also a core faculty member of the Medical Oncology Senior Residency of NUH. He was invited to be an examiner for YLLSOM final year MBBS examinations.

Dr Tan was the principal investigator or co-investigator for several international multi-center cancer clinical trials including novel chemotherapy agents, targeted therapies, tyrosine kinase inhibitors, antibody-drug conjugates, immunotherapy agents, etc. Dr Tan has also authored or co-authored publications in peer-reviewed international journals including Lancet Oncology, Clinical Cancer Research, Molecular Cancer, Lung Cancer, Oncotarget, Target Oncology, Journal of Cancer Research and Clinical Oncology, Journal of Translational Medicine, Journal of Oncology Practice, etc.

Dr Tan is fluent in English, Mandarin, and Malay/Bahasa. He can speak some Cantonese and Hokkien. He has taken care of patients from many regional and overseas regions including Malaysia, Indonesia, Vietnam, Myanmar, China, Bangladesh, Sri Lanka, and India.